Organization named in the records

Synageva Biopharma

Named in 1 passage across 1 document.

Mentions of Synageva Biopharma in the public Epstein records, with citations.

Ask the documents about Synageva Biopharma Search every mention

--}}

Being named in these documents is not an accusation or evidence of wrongdoing. This page reflects only what the public records literally contain, with citations to the original sources.

Where Synageva Biopharma appears

1 total

…nating investments into others. Examples of this type of investment include Intarcia Therapeutics (NLV-I) and Synageva Biopharma (NLV-II, reverse merger to become public - November, 2011, NASDAQ: GEVA,; exited at 7.3x). e Restructuring & Re...

Leadership: NLV_ are leaders in biopharmaceutical investing across all stages and transaction IMAGES-007-HOUSE_OVERSIGHT_024045.txt p.1 View source release ↗

Also named alongside

New Leaf Relypsa Amgen Auxilium Pearl Therapeutics Durata Therapeutics Ilypsa Cerexa Stromedix Chimerix Astra Zeneca Forest Labs

Want context across all of these passages at once?

Ask the documents about Synageva Biopharma